Form D · Other Technology
Cognetivity Neurosciences Ltd.
Vancouver, A1 · CIK 0001995650
Offering snapshot reported Oct 17, 2023 · SEC filing
- Reported sold
- $7.39K Offering amount: $7.39K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 15, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 17, 2023 | Initial | $7,393 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-495000
Total Offering Amount represents 62,500 common shares at C$0.16 per share, converted to US$.
Source: Form D, filed Oct 17, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Desmond Balakrishnan | Director |
| Karimah Es Sabar | Director |
| Sina Habibi | Director, Executive |
| Christos Kalafatis | Director |
| Mark Phillips | Director |
| Thomas Sawyer | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
Suite 1430, 800 West Pender St.
Vancouver, A1, V6C 2V6
Vancouver, A1, V6C 2V6